Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000146473 | SCV000193761 | pathogenic | Severe X-linked myotubular myopathy | 2013-02-08 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000146473 | SCV001201848 | pathogenic | Severe X-linked myotubular myopathy | 2019-12-27 | criteria provided, single submitter | clinical testing | This variant has been observed in individuals affected with myotubular myopathy (PMID: 9305655, 26338224, 12522554). ClinVar contains an entry for this variant (Variation ID: 158994). For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in MTM1 are known to be pathogenic (PMID: 9305655, 10063835). This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Arg222*) in the MTM1 gene. It is expected to result in an absent or disrupted protein product. |
Division of Human Genetics, |
RCV000146473 | SCV004024490 | pathogenic | Severe X-linked myotubular myopathy | 2023-07-01 | criteria provided, single submitter | research | |
Clinical Molecular Genetics Laboratory, |
RCV000146473 | SCV000920407 | pathogenic | Severe X-linked myotubular myopathy | 2009-11-24 | no assertion criteria provided | clinical testing |